Difference between revisions of "Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5 (Q9615)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Third Author string (P151): Rheingold SR, #quickstatements; #temporary_batch_1589999365427)
(‎Created claim: Page(s) (P105): 108-, #quickstatements; #temporary_batch_1590074839150)
 
(5 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 24904824 / rank
 +
Normal rank
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
Front. Oncol.
Property / Published In Name String: Front. Oncol. / rank
 +
Normal rank
Property / Volume
 +
4
Property / Volume: 4 / rank
 +
Normal rank
Property / title
 +
Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English)
Property / title: Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English) / rank
 +
Normal rank
Property / Page(s)
 +
108-
Property / Page(s): 108- / rank
 +
Normal rank

Latest revision as of 15:38, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Tasian SK
    0 references
    Teachey DT
    0 references
    Rheingold SR
    0 references
    0 references
    2014
    0 references
    Front. Oncol.
    0 references
    4
    0 references
    Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies (English)
    0 references
    108-
    0 references